Inventor · disambiguated record
Matthew Colin Thor Fyfe
Also filed as: FYFE MATTHEW · FYFE MATTHEW C · FYFE MATTHEW C T · FYFE MATTHEW COLIN THOR
62 granted patents·46 pending applications·465 citations·filing 2001–2024
98Inventor score
Files withRESPIVERT LTD20ORYZON GENOMICS SA14FYFE MATTHEW COLIN THOR13SITRYX THERAPEUTICS LTD12PROSIDION LTD9
Top patents by PatentIndex Score
108 records- 0197US8927563B2Kinase inhibitorRESPIVERT LTD·Filed 2014·Granted Jan 6, 2015·39 cites·6 claims
- 0296US9499486B2Kinase inhibitorRESPIVERT LTD·Filed 2015·Granted Nov 22, 2016·14 cites·10 claims
- 0396US9149447B2Lysine specific demethylase-1 inhibitors and their useORYZON GENOMICS SA·Filed 2014·Granted Oct 6, 2015·20 cites·5 claims
- 0495US9186337B2Lysine demethylase inhibitors for diseases and disorders associated with HepadnaviridaeBAKER JONATHAN ALLEMAN·Filed 2011·Granted Nov 17, 2015·87 cites·20 claims
- 0594US8722743B2Lysine specific demethylase-1 inhibitors and their useORTEGA MUNOZ ALBERTO·Filed 2011·Granted May 13, 2014·28 cites·69 claims
- 0693US9481648B2Kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Nov 1, 2016·22 cites·24 claims
- 0790US10125100B2Kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Nov 13, 2018·6 cites·4 claims
- 0889US9751837B2Kinase inhibitorsRESPIVERT LTD·Filed 2015·Granted Sep 5, 2017·6 cites·25 claims
- 0989US9670136B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2016·Granted Jun 6, 2017·8 cites·26 claims
- 1089US9181198B2Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical useORTEGA MUÑOZ ALBERTO·Filed 2011·Granted Nov 10, 2015·17 cites·63 claims
- 1189US9006449B2Cyclopropylamine derivatives useful as LSD1 inhibitorsFYFE MATTHEW COLIN THOR·Filed 2011·Granted Apr 14, 2015·19 cites·26 claims
- 1289US8946296B2Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their useORTEGA MUÑOZ ALBERTO·Filed 2010·Granted Feb 3, 2015·17 cites·33 claims
- 1389US8859555B2Lysine Specific Demethylase-1 inhibitors and their useORTEGA MUÑOZ ALBERTO·Filed 2010·Granted Oct 14, 2014·18 cites·23 claims
- 1487US9822076B2Kinase inhibitorRESPIVERT LTD·Filed 2016·Granted Nov 21, 2017·3 cites·3 claims
- 1587US9708309B2Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical useORYZON GENOMICS SA·Filed 2015·Granted Jul 18, 2017·7 cites·12 claims
- 1686US9676701B2Cyclopropylamine derivatives useful as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2015·Granted Jun 13, 2017·7 cites·20 claims
- 1786US9487512B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2012·Granted Nov 8, 2016·8 cites·60 claims
- 1886US9469597B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2012·Granted Oct 18, 2016·8 cites·14 claims
- 1984US9944601B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2016·Granted Apr 17, 2018·4 cites·19 claims
- 2084US9061966B2Cyclopropylamine inhibitors of oxidasesLARIA JULIO CASTRO-PALOMINO·Filed 2011·Granted Jun 23, 2015·24 cites·22 claims
- 2183US9890185B2Urea derivatives useful as kinase inhibitorsRESPIVERT LTD·Filed 2014·Granted Feb 13, 2018·8 cites·18 claims
- 2283US9796742B2Kinase inhibitorsRESPIVERT LTD·Filed 2016·Granted Oct 24, 2017·2 cites·23 claims
- 2383US9771353B2Kinase inhibitors based upon N-alkyl pyrazolesRESPIVERT LTD·Filed 2014·Granted Sep 26, 2017·3 cites·19 claims
- 2483US9701670B2Pyrazolyl-ureas as kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted Jul 11, 2017·10 cites·18 claims
- 2582US10435361B2Kinase inhibitorsTOPIVERT PHARMA LTD·Filed 2017·Granted Oct 8, 2019·3 cites·22 claims
- 2682US10392346B2Kinase inhibitorsTOPIVERT PHARMA LTD·Filed 2018·Granted Aug 27, 2019·2 cites·6 claims
- 2782US10072034B2Kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Sep 11, 2018·3 cites·23 claims
- 2880US7282592B2Resorcinol derivativesWARNER LAMBERT CO·Filed 2006·Granted Oct 16, 2007·3 cites·23 claims
- 2978US9908859B2Lysine demethylase inhibitors for myeloproliferative disordersORYZON GENOMICS SA·Filed 2014·Granted Mar 6, 2018·6 cites·16 claims
- 3078US7262196B2Tri(cyclo) substituted amide glucokinase activator compoundsPROSIDION LTD·Filed 2004·Granted Aug 28, 2007·11 cites·17 claims
- 3178US6590105B2Resorcinol derivativesWARNER LAMBERT CO·Filed 2001·Granted Jul 8, 2003·8 cites·13 claims
- 3276US10329256B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2018·Granted Jun 25, 2019·1 cites·19 claims
- 3375US10301288B2Kinase inhibitorsTOPIVERT PHARMA LTD·Filed 2017·Granted May 28, 2019·1 cites·4 claims
- 3475US10214477B2(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitorsORYZON GENOMICS SA·Filed 2017·Granted Feb 26, 2019·1 cites·8 claims
- 3574US10233178B2Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical useORYZON GENOMICS SA·Filed 2017·Granted Mar 19, 2019·1 cites·5 claims
- 3674US8207147B2Heterocyclic derivatives as GPCR receptor agonistsFYFE MATTHEW COLIN THOR·Filed 2004·Granted Jun 26, 2012·10 cites·11 claims
- 3773US7214681B2Tri(cyclo) substituted amide compoundsPROSIDION LTD·Filed 2004·Granted May 8, 2007·7 cites·16 claims
- 3871US7057048B2Androgen receptor antagonistsWARNER LAMBERT CO·Filed 2004·Granted Jun 6, 2006·6 cites·14 claims
- 3970US10202330B2Lysine specific demethylase-1 inhibitors and their useORYZON GENOMICS SA·Filed 2015·Granted Feb 12, 2019·1 cites·2 claims
- 4070US7173052B2Resorcinol derivativesPFIZER PROD INC·Filed 2004·Granted Feb 6, 2007·3 cites·27 claims
- 4170US6852747B2Resorcinol derivativesPFIZER·Filed 2003·Granted Feb 8, 2005·3 cites·9 claims
- 4269US10941115B2Kinase inhibitorsOXULAR ACQUISITIONS LTD·Filed 2019·Granted Mar 9, 2021·0 cites·17 claims
- 4369US8193359B2G-protein coupled receptor agonistsFYFE MATTHEW COLIN THOR·Filed 2005·Granted Jun 5, 2012·2 cites·14 claims
- 4467US7064207B2Androgen receptor antagonistsWARNER LAMBERT CO·Filed 2004·Granted Jun 20, 2006·4 cites·16 claims
- 4565US6541473B2Resorcinol derivativesWARNER LAMBERT CO·Filed 2001·Granted Apr 1, 2003·2 cites·29 claims
- 4662US6797731B2Resorcinol derivativesPFIZER·Filed 2003·Granted Sep 28, 2004·1 cites·6 claims
- 4760US7098340B2Benzyl sulfonamide derivativesWARNER LAMBERT CO·Filed 2004·Granted Aug 29, 2006·1 cites·11 claims
- 4860US2025122212A1Novel compoundsSITRYX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 4958US2016016934A1Kinase inhibitorsRESPIVERT LTD·Filed 2014·Application pending·0 cites
- 5056US10882859B2Kinase inhibitorsTOPIVERT PHARMA LTD·Filed 2019·Granted Jan 5, 2021·0 cites·21 claims
Showing the top 50 of 108 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Matthew Colin Thor Fyfe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →